d
dRx Capital
Switzerland
Overview
dRx Capital backs exceptional entrepreneurs transforming healthcare through data and digital technology . The fund, backed by Novartis, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization .
Year Founded
2015
Portfolio Companies
17
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Yseop | Dec 2023 | Strategic | - |
| Octave Bioscience | Jul 2023 | Series B Extension | - |
| RxLightning | Jun 2023 | Series A | Co-investor |
| Holmusk | Jan 2023 | Series B | Co-investor |
| Peptone | Jun 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
